fbpx

2:45 – 3:00

GS6-03. Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment ingermline BRCA mutation carriers (BRCA carriers) with HER2-negative breast cancer: Results from the INFORM trial (TBCRC 031)

Social Share